World Journal of Gastroenterology - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 33

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2774)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-4) series, Tables (1-5) series.

Item

Count

PDF

276

HTML

2232

Figures (1-4)

136

Tables (1-5)

130

Sum=2774

Sep 7, 2006 (publication date) through Apr 16, 2024

Times Cited of This Article

Times Cited (11)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef

For:	Buzás GM, Józan J. First-line eradication of H pylori infection in Europe: A meta-analysis based on congress abstracts, 1997-2004. World J Gastroenterol 2006; 12(33): 5311-5319 [PMID: 16981260 DOI: 10.3748/wjg.v12.i33.5311]
URL:	https://www.wjgnet.com/1007-9327/full/v12/i33/5311.htm

Number	Citing Articles
1	David Y. Graham, Maria Pina Dore. Helicobacter pyloritherapy: a paradigm shift. Expert Review of Anti-infective Therapy 2016; 14(6): 577 doi: 10.1080/14787210.2016.1178065
2	Quan Zhou, Ling-Ling Zhu, Xiao-Feng Yan, Wen-Sheng Pan, Su Zeng. Drug utilization of clarithromycin for gastrointestinal disease treatment. World Journal of Gastroenterology 2008; 14(39): 6065-6071 doi: 10.3748/wjg.14.6065 Abstract(708) \| Core Tip(542) \| Full Article(HTML)(1882) \| Full Article (PDF)-762K(287) \| Times Cited (3) \| Total Visits (3717) \| Open
3	Keval A. Patel, Colin W. Howden. Update on the Diagnosis and Management of Helicobacter pylori Infection in Adults. Journal of Clinical Gastroenterology 2015; 49(6): 461 doi: 10.1097/MCG.0000000000000318
4	György Miklós Buzás. Helicobacter pylori – 2010. Orvosi Hetilap 2010; 151(49): 2003 doi: 10.1556/oh.2010.28982
5	Suat Moi Puah, Khean Lee Goh, Heng Kang Ng, Kek Heng Chua. Current status ofHelicobacter pyloriresistance to Clarithromycin and Levofloxacin in Malaysia—findings from a molecular based study. PeerJ 2021; 9: e11518 doi: 10.7717/peerj.11518
6	J. Gaillat. Imidazoles. EMC - Tratado de Medicina 2010; 14(1): 1 doi: 10.1016/S1636-5410(10)70520-1
7	Yuhong Yuan, Alex C Ford, Khurram J Khan, Javier P Gisbert, David Forman, Grigorios I Leontiadis, Frances Tse, Xavier Calvet, Carlo Fallone, Lori Fischbach, Giuseppina Oderda, Franco Bazzoli, Paul Moayyedi. Optimum duration of regimens forHelicobacter pylorieradication. Cochrane Database of Systematic Reviews 2013; doi: 10.1002/14651858.CD008337.pub2
8	J. P. Gisbert, X. Calvet. Review article: the effectiveness of standard triple therapy for Helicobacter pylori has not changed over the last decade, but it is not good enough. Alimentary Pharmacology & Therapeutics 2011; 34(11-12): 1255 doi: 10.1111/j.1365-2036.2011.04887.x
9	Javier P. Gisbert, Adrian G. McNicholl. Maintenance of Helicobacter pylori Eradication Rates with Triple Therapy Over 12 Years in a Spanish hospital. Helicobacter 2012; 17(2): 160 doi: 10.1111/j.1523-5378.2011.00922.x
10	Yuhong Yuan, Alex C Ford, Khurram J Khan, David Forman, Giuseppina Oderda, Xavier Calvet, Grigorios I Leontiadis, Carlo Fallone, Javier P Gisbert, Lori Fischbach, Franco Bazzoli, Paul Moayyedi, Yuhong Yuan. Cochrane Database of Systematic Reviews. 2010; doi: 10.1002/14651858.CD008337
11	J. Gaillat. Imidazolés. EMC - Traité de médecine AKOS 2009; 4(3): 1 doi: 10.1016/S1634-6939(09)51950-3